Session

Back to Programme Overview

Updated renal, bladder and prostate cancer guidelines 2017: What has changed?

ESU Course 40

  • Location:
    Room 17, Capital suite (level 3)
  • Chair:
     A. Volpe, Novara (IT)
  • Aims and objectives of this session

    During the course recent practice changing alterations in the guidelines will be discussed. Based on the clinical recommendations the highlights of the guidelines one prostate, renal and bladder cancer as changed in the 2016 updates will be presented and illustrated by clinical cases. A basic knowledge of the guidelines information is assumed for participating trainees.

Introduction
 A. Volpe, Novara (IT)
Update renal cancer: Localized
 A. Volpe
Discussion
Update renal cancer: Metastasized
 A. Volpe
Discussion
Update bladder cancer: Non-muscle invasive
 B.W.G. Van Rhijn, Amsterdam (NL)
Discussion
Update bladder cancer: Muscle invasive
 B.W.G. Van Rhijn, Badhoevedorp (NL)
Discussion
Update prostate cancer: Localized
 R.J.A. Van Moorselaar, Amsterdam (NL)
Discussion
Update prostate cancer: Metastasized
 R.J.A. Van Moorselaar, Amsterdam (NL)